滑膜组织中MMP-13与β-catenin对于骨关节炎严重程度的评估价值

Abstract
Figure/Table
References
Related Citation (14)

Download: PDF (792 KB) HTML (0 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the value of matrix metalloproteinase-13 (MMP-13) and beta-catenin in evaluating the severity of osteoarthritis (OA).Methods 92 OA patients were selected from the 922 Hospital of PLA joint logistics support force from April 2017 to April 2019,According to the severity of the disease, they were divided into mild group (n=47) and moderate / severe group (n=45).The positive and negative expressions of MMP-13 and beta-catenin in synovial tissues of all patients were detected by immunohistochemistry.The expression of MMP-13 and beta-catenin in synovial tissue was determined by reverse transcription assay. The ROC was drawn to analyze the predictive value of MMP-13 and beta-catenin expression on the severity of OA.Results The positive rates of MMP-13 and beta-catenin in mild group were 68.09% and 55.32% respectively, which were significantly lower than those in moderate/severe group (88.89% and 75.56%, respectively) (P<0.05).The negative rates of MMP-13 and beta-catenin in mild group were 31.91% and 44.68% respectively, which were significantly higher than those in moderate/severe group (11.11% and 24.44%, respectively) (P<0.05).The expression of MMP-13 and beta-catenin in mild group was significantly lower than that in moderate/severe group (P<0.05).The area under the curve of MMP-13 and beta-catenin expression predicting OA severity was 0.656 and 0.683, respectively. When MMP-13 > 0.887 and beta-catenin >1.975, the higher the risk of developing to moderate or severe.Conclusions With the severity of OA, the higher the positive rate of MMP-13 and beta-catenin, and the higher the expression of MMP-13 and beta-catenin in synovial tissue, the expression of MMP-13 and beta-catenin has a certain predictive value for the severity of OA.

Key words： osteoarthritis synovial tissue matrix metalloproteinase-13 β-catenin severity

Received: 20 May 2020

ZTFLH:

R684

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHU Zhiyong
	WU Kaiyuan
	WANG Haijun
	YUAN Yongduan
	ZHANG Wei
	ZHU Fan

Cite this article:

ZHU Zhiyong,WU Kaiyuan,WANG Haijun等. Value of detecting MMP-13 and beta-catenin in synovial tissue in evaluating the severity of osteoarthritis[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2021, 32(6): 490-493.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2021/V32/I6/490

[1]	Scanzello C R. Role of low-grade inflammation in osteoarthritis[J]. Curr Opin Rheumatol, 2017,29(1):79-85.
[2]	Mobasheri A, Rayman M P, Gualillo O, et al. The role of metabolism in the pathogenesis of osteoarthritis.[J]. Nat Rev Rheumatol, 2017, 13(5):302-311.
[3]	Duymus T M, Mutlu S, Dernek B, et al. Choice of intra-articular injection in treatment of knee osteoarthritis: platelet-rich plasma, hyaluronic acid or ozone options[J]. Knee Surg Sport Tr A, 2017, 25(2):1-8.
[4]	黄媛霞, 徐海斌, 郭春. 白细胞介素-1β、肿瘤坏死因子α及基质金属蛋白酶13在骨性关节炎中的表达及相关性[J]. 广东医学, 2017, 38(15): 2301-2304.
[5]	王婉莹, 彩云, 孙丽艳,等.Wnt/β-catenin信号通路在骨关节炎和大骨节病发病中的作用及研究进展[J].中华地方病学杂志, 2018, 37(11): 933-936.
[6]	中华医学会骨科学分会. 骨关节炎诊治指南(2007年版)[J]. 中国矫形外科杂志, 2014, 27(3): 28-30.
[7]	符维广, 许立新. 晚期骨关节炎患者血清和关节液中基质金属蛋白酶-13和肿瘤坏死因子-α水平的变化及其意义[J]. 中国骨与关节杂志,2017,6(4):279-282.
[8]	范凯健, 吴菁, 李钦,等. 基质金属蛋白酶13在软骨重塑和关节炎中的研究进展[J]. 中国药理学通报, 2018, 34(5):607-611.
[9]	杨立群, 张国彬, 习瑾昆,等. 膝关节软骨中基质金属蛋白酶13及其组织抑制剂1的表达[J]. 中国组织工程研究, 2015, 19(15):2310-2314.
[10]	扶小华, 田猛, 戴东. 基质金属蛋白酶-13及星状细胞的研究进展[J]. 中国实验诊断学, 2017, 21(8):1468-1469.
[11]	乔虎军, 王国祥, 郝鑫. 转化生长因子β/Smad信号通路和骨关节炎研究进展[J]. 中国运动医学杂志, 2019, 38(2):63-71.
[12]	刘兴振, 范洁, 李甲,等. 骨关节炎关节软骨自然退变过程中Dvl2及β-catenin表达变化[J]. 中国现代应用药学, 2016, 33(11):1355-1358.
[13]	李钦宗, 魏万利, 郑昆仑,等. 关节清理术对膝骨关节炎患者白细胞介素-18、基质金属蛋白酶-13表达的影响[J]. 中国中西医结合外科杂志,2017,23(4):415-418.
[14]	张思成,袁亮,宁波,等.大鼠DDH关节软骨早期退变和X型胶原、基质金属蛋白酶13表达相关性的研究[J].安徽医科大学学报,2015,50(6):765-769.
[15]	周振华, 肖建如. Wnt/β-catenin信号转导通路对骨形成和骨肿瘤的调控作用[J].中华外科杂志,2018, 56(10):797-800.